Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolismJean‐Charles Lambert, Adrien Herlédan, Florie Demiautte et al.|Acta Neuropathologica|2016Cited by 78
Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent mannerFanny Eysert, Julien Chapuis, Audrey Coulon et al.|Molecular Psychiatry|2020Cited by 59
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Jean‐Charles Lambert, Geoffroy Laumet et al.|EBioMedicine|2016Cited by 52
Pyk2 overexpression in postsynaptic neurons blocks amyloid β1–42-induced synaptotoxicity in microfluidic co-culturesDevrim Kilinc, Jean‐Charles Lambert, Anaïs-Camille Vreulx et al.|Brain Communications|2020Cited by 28
Calpain and caspase regulate Aβ peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2Chloé Najdek, Julien Chapuis, Pauline Walle et al.|Neurobiology of Aging|2025Cited by 1